Novadip Biosciences raises $12.0M Convertible (Belgium, Sep 2026)
Reach the investors backing rounds like this
Backed by New Science Ventures, Fund+ +6 more · verified emails and LinkedIn on Datapile
Belgium's Novadip Biosciences raises €10.4 million to fund pivotal clinical trial and unlock EIB loan tranche - EU-Startups
Novadip Biosciences is a Belgian late-stage clinical biotech company specializing in regenerative medicine. They have developed a proprietary platform using adipose-derived stem cells to create tissue for healing bone defects and fractures. This funding will support their pivotal Phase 3 clinical trial for NVD003 and preparation for regulatory submission in the United States.
Belgium's Novadip Biosciences raises €10.4 million to fund pivotal clinical trial and unlock EIB loan tranche EU-Startups
| Oct 09, 2026 | SpectaCell | $6.0M | Seed | Belgium |
| Oct 06, 2026 | Zymofix | $7.0M | Series A | Belgium |
| Sep 18, 2026 | TUSK IC | $15.0M | Series A | Belgium |
| Sep 10, 2026 | IVEX | $5.0M | Series A | Belgium |
2,912 investors back startups in Belgium
You just read who funded Novadip Biosciences. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.